- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 17/14 - Drugs for dermatological disorders for baldness or alopecia
Patent holdings for IPC class A61P 17/14
Total number of patents in this class: 1444
10-year publication summary
50
|
59
|
47
|
69
|
113
|
164
|
132
|
178
|
188
|
56
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Allergan, Inc. | 2600 |
27 |
The Regents of the University of California | 18943 |
23 |
Caregen Co., Ltd. | 241 |
23 |
Giuliani S.p.A. | 286 |
17 |
Taisho Pharmaceutical Co., Ltd. | 844 |
14 |
Sumitomo Chemical Company, Limited | 8808 |
13 |
AMOREPACIFIC Corporation | 2606 |
13 |
Aneira Pharma, Inc. | 13 |
12 |
Pierre Fabre Dermo-Cosmetique | 380 |
11 |
Shiseido Company, Ltd. | 3761 |
11 |
Johnson & Johnson Consumer Inc. | 1277 |
10 |
Henkel AG & Co. KGaA | 10129 |
9 |
Adjuvant Holdings Co.,Ltd. | 13 |
9 |
The Trustees of the University of Pennsylvania | 4122 |
8 |
Daiichi Sankyo Company, Limited | 1829 |
8 |
Industry-Academic Cooperation Foundation, Yonsei University | 2329 |
8 |
Kyushu University, National University Corporation | 1572 |
8 |
Theravance Biopharma R&D IP, LLC | 550 |
8 |
Samson Clinical Pty Ltd | 10 |
8 |
Beijing Scitech-mq Pharmaceuticals Limited | 36 |
8 |
Other owners | 1196 |